Article
Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive…
medRxiv · 2020 · Shimano, H.; Nakagawa, Y.; Yunong Wang, Y.; Han, S.-i.; Okuda, K.; Oishi, A.; Yagishita, Y.; Kumagai, K.; Ohno, H.; Osaki, Y.; Mizunoe, Y.; Murayama, Y.; Iwasaki, H.; Konishi, M.; Itoh, N.; Matsuzaka, T.; Sone, H.; Yamada, N.; Araki, M.
Key facts
| Title | Enterohepatic Transcription Factor CREB3L3 Protects Atherosclerosis via SREBP Competitive Inhibition |
|---|---|
| First author | Shimano, H.; Nakagawa, Y.; Yunong Wang, Y.; Han, S.-i.; Okuda, K.; Oishi, A.; Yagishita, Y.; Kumagai, K.; Ohno, H.; Osaki, Y.; Mizunoe, Y.; Murayama, Y.; Iwasaki, H.; Konishi, M.; Itoh, N.; Matsuzaka, T.; Sone, H.; Yamada, N.; Araki, M. |
| Journal | medRxiv |
| Published | May 1, 2020 |
| DOI | 10.1101/2020.04.29.069260 |
| Devices mentioned | K040471, K040692, K100010, K103302, K925155 |
| Product codes mentioned | CIT, IDO, IDW, IDZ, IEO, JIT, KDT, KEQ, KER, KES, KIM, KIO and 10 more |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1